Market Tracker

09/23 5:16pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.58
Delayed Data
As of Sep 23
 -0.14 / -3.76%
Today’s Change
1.63
Today|||52-Week Range
9.42
+77.23%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.72
Today’s open3.65
Day’s range3.57 - 3.74
Volume31,933
Average volume (3 months)94,341
Market cap$40.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+82.99%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXNAoxing Pharmaceutica...-0.01-1.37%
TKAITokai Pharmaceutical...+0.03+1.82%
CTRVContraVir Pharmaceut...+0.02+1.74%
MRNSMarinus Pharmaceutic...+0.46+26.14%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts